Metus comments on Expansion on A Previous Cost-Benefit Analysis of Vaccinating Healthy Adults Against Flu - Less Wrong
You are viewing a comment permalink. View the original post to see all comments and the full post content.
You are viewing a comment permalink. View the original post to see all comments and the full post content.
Comments (6)
Thank you for doing a follow up.
A couple of thoughts:
All in all, the benefit for healthy adults with no major social contact during the day the benefit is marginal except for the risk of death. Personally, I am seriously considering getting the shot.
Thank you for the feedback and compliments. Here are some brief responses to points 1, 2, and 4:
In response to 1:
Yes, this definitely seems true.
In response to 2:
Mine does. This seems to be the case for many people in the US, at least. I would guess that private insurance companies would be more diligent about actually doing cost-benefit analyses on these sorts of issues than the people behind governmental insurance programs, though I would hope that e.g. the NHS in the UK wouldn't be too blind to the fact that conducting cost-benefit analyses of various interventions is a good idea.
I think that many people value their own lives as being worth more than the payout of their life insurance policy. A quick Google search makes it look like typical life insurance policies pay 250,000 to 1,000,000 USD, while I estimated the average person as valuing their life at 5,000,000 USD in the analysis.
In response to 4:
This is a fair criticism. I think that this would be a good reason to get vaccinated in October, or early November, before quite as many people tend to be sick.